Tango Therapeutics, Inc.
Here’s whether Tango Therapeutics, Inc. (TNGX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+5.56% over 10 days); strong 1-year return of +512.7%; 3-month momentum positive (+73.0%); rising volume confirms the move (1.60x 30d avg). Concerns: RSI 72 — overbought, elevated pullback risk. Currently 5.6% off its 52-week high. Score: +6/7.
TNGX is in a confirmed uptrend, trading above both its 50-day ($23.50) and 200-day ($13.85) moving averages. With an RSI of 71.6, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +512.7% compares to +22.9% for SPY (beat the market by 489.8%).